Literature DB >> 327555

Combination chemotherapy--theory and practice.

R L Capizzi, L W Keiser, A C Sartorelli.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 327555

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  6 in total

Review 1.  Pharmacokinetic drug interactions of commonly used anticancer drugs.

Authors:  F M Balis
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

Review 2.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

3.  Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines.

Authors:  Julie Scott; Robert T Dorr; Betty Samulitis; Terry H Landowski
Journal:  Cancer Chemother Pharmacol       Date:  2007-02-28       Impact factor: 3.333

4.  Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay.

Authors:  T Saito; M E Berens; C E Welander
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Enhanced activity of anticancer drugs in murine tumours by co-administration with 3-amino-pyrrolidine-2,5-dione-N-mustard derivative.

Authors:  R Y Ambaye; M A Indap; S D Naik
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

6.  Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study.

Authors:  A Desjonquères; P Chevallier; X Thomas; F Huguet; T Leguay; M Bernard; J-O Bay; E Tavernier; A Charbonnier; F Isnard; M Hunault; P Turlure; M Renaud; J-N Bastié; C Himberlin; S Lepretre; B Lioure; V Lhéritier; V Asnafi; K Beldjord; M Lafage-Pochitaloff; M C Béné; N Ifrah; H Dombret
Journal:  Blood Cancer J       Date:  2016-12-09       Impact factor: 11.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.